TY - JOUR
T1 - Inhibition of tumor necrosis factor alpha (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury
AU - Shohami, E.
AU - Bass, R.
AU - Wallach, D.
AU - Yamin, A.
AU - Gallily, R.
PY - 1996
Y1 - 1996
N2 - We recently demonstrated that closed head injury (CHI) in the rat triggers the production of tumor necrosis factor alpha (TNFα) in the contused hemisphere. Other investigations have shown that this cytokine plays a role in the inflammatory response following trauma. The present study was designed to determine whether inhibition of TNFα production or activity affects the development of cerebral edema as well as neurological dysfunction and hippocampal cell loss after CHI. To this end, we used two pharmacological agents, each acting via a different mechanism: pentoxifylline (PTX), which attenuates the production of TNFα, and tumor necrosis factor binding protein (TBP), a physiological inhibitor of TNFα activity. Both agents significantly lessened peak edema formation at 24 h and facilitated the recovery of motor function for ≤14 days postinjury. In addition, TBP attenuated disruption of the blood-brain barrier and protected hippocampal cells. PTX significantly lowered the brain TNFα level (by ~80%), and TBP completely abolished the activity of recombinant human TNF when they were added at the same time in the in vitro bioassay. We suggest, therefore, that a decrease in TNFα level or the inhibition of its activity is accompanied by reduced brain damage.
AB - We recently demonstrated that closed head injury (CHI) in the rat triggers the production of tumor necrosis factor alpha (TNFα) in the contused hemisphere. Other investigations have shown that this cytokine plays a role in the inflammatory response following trauma. The present study was designed to determine whether inhibition of TNFα production or activity affects the development of cerebral edema as well as neurological dysfunction and hippocampal cell loss after CHI. To this end, we used two pharmacological agents, each acting via a different mechanism: pentoxifylline (PTX), which attenuates the production of TNFα, and tumor necrosis factor binding protein (TBP), a physiological inhibitor of TNFα activity. Both agents significantly lessened peak edema formation at 24 h and facilitated the recovery of motor function for ≤14 days postinjury. In addition, TBP attenuated disruption of the blood-brain barrier and protected hippocampal cells. PTX significantly lowered the brain TNFα level (by ~80%), and TBP completely abolished the activity of recombinant human TNF when they were added at the same time in the in vitro bioassay. We suggest, therefore, that a decrease in TNFα level or the inhibition of its activity is accompanied by reduced brain damage.
KW - Brain injury
KW - Pentoxifylline
KW - Tumor necrosis factor alpha (TNFα)
KW - Tumor necrosis factor binding protein
UR - http://www.scopus.com/inward/record.url?scp=0029926093&partnerID=8YFLogxK
U2 - 10.1097/00004647-199605000-00004
DO - 10.1097/00004647-199605000-00004
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0029926093
SN - 0271-678X
VL - 16
SP - 378
EP - 384
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
IS - 3
ER -